Ji Yao Holding Group Co Ltd banner

Ji Yao Holding Group Co Ltd
SZSE:300108

Watchlist Manager
Ji Yao Holding Group Co Ltd Logo
Ji Yao Holding Group Co Ltd
SZSE:300108
Watchlist
Price: 0.21 CNY Market Closed
Market Cap: ¥139.9m

Relative Value

The Relative Value of one Ji Yao Holding Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 0.21 CNY, Ji Yao Holding Group Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Ji Yao Holding Group Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Ji Yao Holding Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Ji Yao Holding Group Co Ltd
SZSE:300108
139.9m CNY 0.4 -0.3 -4.6 -4.6
US
Eli Lilly and Co
NYSE:LLY
970.2B USD 14.7 46.5 31.4 33.5
US
Johnson & Johnson
NYSE:JNJ
596.3B USD 6.3 22.3 15.5 19
CH
Roche Holding AG
SIX:ROG
288.1B CHF 4.7 30.6 12.9 15.1
CH
Novartis AG
SIX:NOVN
250B CHF 5.7 23 14.2 18.2
UK
AstraZeneca PLC
LSE:AZN
237.1B GBP 5.4 31.2 17.3 24.4
US
Merck & Co Inc
NYSE:MRK
300.1B USD 4.6 16.4 10.2 12.4
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK 3.4 10.3 7.6 8.9
US
Pfizer Inc
NYSE:PFE
155.3B USD 2.5 19.9 7.7 10.2
US
Bristol-Myers Squibb Co
NYSE:BMY
125B USD 2.6 17.8 7.4 9.1
P/E Multiple
Earnings Growth PEG
CN
Ji Yao Holding Group Co Ltd
SZSE:300108
Average P/E: 24.2
Negative Multiple: -0.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.5
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.3
7%
3.2
CH
Roche Holding AG
SIX:ROG
30.6
29%
1.1
CH
Novartis AG
SIX:NOVN
23
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
31.2
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.4
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.9
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.8
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Ji Yao Holding Group Co Ltd
SZSE:300108
Average EV/EBITDA: 46.9
Negative Multiple: -4.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.4
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.5
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
CH
Novartis AG
SIX:NOVN
14.2
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
17.3
13%
1.3
US
Merck & Co Inc
NYSE:MRK
10.2
3%
3.4
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.6
2%
3.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Ji Yao Holding Group Co Ltd
SZSE:300108
Average EV/EBIT: 101.6
Negative Multiple: -4.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.5
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
19
7%
2.7
CH
Roche Holding AG
SIX:ROG
15.1
6%
2.5
CH
Novartis AG
SIX:NOVN
18.2
9%
2
UK
AstraZeneca PLC
LSE:AZN
24.4
21%
1.2
US
Merck & Co Inc
NYSE:MRK
12.4
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
3%
3
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.1
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett